Biotech Week
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Week
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Collaborations
Cumbre Pharmaceuticals and TB Alliance announce partnership to develop new TB agents
October 25th, 2006
Cumbre Pharmaceuticals Inc, a Dallas-based biopharmaceutical company, and the Global Alliance for TB Drug Development (TB Alliance), a public-private partnership developing affordable new TB drugs, announced plans to pursue a joint program to develop new, promising anti-tuberculosis agents. Under the terms of the agreement, the parties will work on the design, synthesis and optimization of two different classes of multi-functional antibiotics. The collaboration will utilize Cumbre's unique antibiotic discovery and development technical platform to deliver novel antibiotic compounds. The TB Alliance will have exclusive rights to these compounds for the treatment of...
Source: Biotech Week (2006-10-25)
|
